Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Optical Coherence Tomography Guided Treat and Extend Therapy for Neovascular Age Related Macular Degeneration Using Aflibercept (the ATLAS Study)

NCT01773954 is registered in ClinicalTrials.gov with MidAtlantic Retina as lead sponsor.

NCT NCT01773954
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01773954 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Optical Coherence Tomography Guided Treat and Extend Therapy for Neovascular Age Related Macular Degeneration Using Aflibercept (the ATLAS Study)
Lead sponsor
MidAtlantic Retina
Phase
Not applicable
Overall status
Completed
Start date
February 28, 2013
Completion date
March 31, 2016
Enrollment
40 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

age-related macular degeneration, macular degeneration